title: Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months increases cancellous bone formation and improves cancellous architecture: a study of iliac crest biopsies using histomorphometry and micro computed tomography.
authors.affiliation: NPS Pharmaceuticals, Salt Lake City, UT 84108, USA. jfox@npsp.com
authors.forename: J
authors.initials: J
authors.lastname: Fox
authors.forename: M A
authors.initials: MA
authors.lastname: Miller
authors.forename: R R
authors.initials: RR
authors.lastname: Recker
authors.forename: S P
authors.initials: SP
authors.lastname: Bare
authors.forename: S Y
authors.initials: SY
authors.lastname: Smith
authors.forename: I
authors.initials: I
authors.lastname: Moreau
mesh_terms: D000368:Aged; D001846:Bone Development / Q000187:drug effects*; D001842:Bone and Bones / Q000187:drug effects / Q000473:pathology*; D005260:Female; D006801:Humans; D007085:Ilium / Q000473:pathology*; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000473:pathology*; D010281:Parathyroid Hormone / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
chemical_list: D010281:Parathyroid Hormone